![Pfizer, which developed one of the major vaccines for Covid-19, is banking on product launches to boost its bottom line. AP](https://thenational-the-national-prod.cdn.arcpublishing.com/resizer/v2/OTWOVPG7NINPZQTVJ5V5B3RR5I.jpg?smart=true&auth=3f293a3c9df1ca0d3dca2d895c76f3d491398ca7943999f6cae0218f106db784&width=400&height=225)
Pfizer, which developed one of the major vaccines for Covid-19, is banking on product launches to boost its bottom line. AP
Pfizer, which developed one of the major vaccines for Covid-19, is banking on product launches to boost its bottom line. APPfizer's Q2 profit slumps 77% as Covid product sales decline
Revenue dropped by a bigger-than-expected 54% to $12.73bn, from $27.74bn in the same period in 2022